These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24590803)

  • 1. Essential medicines for COPD and asthma in low and middle-income countries.
    Bazargani YT; de Boer A; Leufkens HG; Mantel-Teeuwisse AK
    Thorax; 2014 Dec; 69(12):1149-51. PubMed ID: 24590803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review.
    Stolbrink M; Thomson H; Hadfield RM; Ozoh OB; Nantanda R; Jayasooriya S; Allwood B; Halpin DMG; Salvi S; de Oca MM; Mortimer K; Rylance S
    Lancet Glob Health; 2022 Oct; 10(10):e1423-e1442. PubMed ID: 36113528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries.
    Bazargani YT; Ugurlu M; de Boer A; Leufkens HGM; Mantel-Teeuwisse AK
    BMC Cardiovasc Disord; 2018 Jun; 18(1):126. PubMed ID: 29940880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.
    Babar ZU; Lessing C; Mace C; Bissell K
    Pharmacoeconomics; 2013 Nov; 31(11):1063-82. PubMed ID: 24127259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-five statements on early initiation of fixed combination ICS/LABA treatment for asthma and COPD in primary and secondary care: consensus research by a modified Delphi process.
    Kardos P; Bechtel B; Palovis L; Hagedorn C; Latif F
    Pneumologie; 2012 Sep; 66(9):549-57. PubMed ID: 22899206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of the utilisation and expenditure of medicines dispensed for the management of severe asthma.
    McGowan B; Bennett K; Barry M; Owens M; O'Connor M
    Ir Med J; 2009 Mar; 102(3):73-6. PubMed ID: 19489193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood asthma in low and middle-income countries: Where are we now?
    Fischer GB; Sarria EE; Camargos P; Mocelin HT; Soto-Quiroz M; Cruz AA; Bousquet J; Zar HJ
    Paediatr Respir Rev; 2019 Aug; 31():52-57. PubMed ID: 30987798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Corticosteroid treatment in airways narrowing].
    Chazan R
    Pneumonol Alergol Pol; 2008; 76(2):96-100. PubMed ID: 18464224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to Cytotoxic Medicines by Children With Cancer: A Focus on Low and Middle Income Countries.
    Barr R; Robertson J
    Pediatr Blood Cancer; 2016 Feb; 63(2):287-91. PubMed ID: 26375626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of essential medicines for diabetes in low and middle income countries: a survey of 32 national essential medicines lists.
    Bazargani YT; de Boer A; Leufkens HG; Mantel-Teeuwisse AK
    PLoS One; 2014; 9(9):e106072. PubMed ID: 25259517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential medicines availability is still suboptimal in many countries: a scoping review.
    Mahmić-Kaknjo M; Jeličić-Kadić A; Utrobičić A; Chan K; Bero L; Marušić A
    J Clin Epidemiol; 2018 Jun; 98():41-52. PubMed ID: 29452222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability of diagnostic services and essential medicines for non-communicable respiratory diseases in African countries.
    Plum C; Stolbrink M; Zurba L; Bissell K; Ozoh BO; Mortimer K
    Int J Tuberc Lung Dis; 2021 Feb; 25(2):120-125. PubMed ID: 33656423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management.
    Aït-Khaled N; Enarson D; Bousquet J
    Bull World Health Organ; 2001; 79(10):971-9. PubMed ID: 11693980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries.
    Beran D; Zar HJ; Perrin C; Menezes AM; Burney P;
    Lancet Respir Med; 2015 Feb; 3(2):159-170. PubMed ID: 25680912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to essential medicines to treat chronic respiratory disease in low-income countries.
    Bissell K; Perrin C; Beran D
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):717-28. PubMed ID: 27155173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome.
    Nakawah MO; Hawkins C; Barbandi F
    J Am Board Fam Med; 2013; 26(4):470-7. PubMed ID: 23833163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.
    Buhl R; Farmer SG
    Proc Am Thorac Soc; 2004; 1(2):136-42. PubMed ID: 16113426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of oncology medicines in low- and middle-income countries.
    Bazargani YT; de Boer A; Schellens JH; Leufkens HG; Mantel-Teeuwisse AK
    Ann Oncol; 2014 Jan; 25(1):270-6. PubMed ID: 24356638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of asthma mortality with inhaled long acting beta-agonists.
    Wijesinghe M; Perrin K; Harwood M; Weatherall M; Beasley R
    Postgrad Med J; 2008 Sep; 84(995):467-72. PubMed ID: 18940948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.